Determined by the subgroup Assessment, we identified that there was sizeable heterogeneity when it comes to mortality, favorable outcomes, and the whole therapy productive rate. Relating to mortality, the reason for heterogeneity within the subgroup of edaravone dexborneol and EDV was mainly attributed to variations in drug dosage. About favorable https://jaredieawq.bloggactif.com/34473633/5-tips-about-what-are-the-best-neuroprotective-drugs-you-can-use-today